Literature DB >> 15785761

Natural regulatory T cells in infectious disease.

Yasmine Belkaid1, Barry T Rouse.   

Abstract

This review discusses the control exerted by natural CD4(+) CD25(+) regulatory T cells (natural T(reg) cells) during infectious processes. Natural T(reg) cells may limit the magnitude of effector responses, which may result in failure to adequately control infection. However, natural T(reg) cells also help limit collateral tissue damage caused by vigorous antimicrobial immune responses. We describe here various situations in which the balance between natural T(reg) cells and effector immune functions influences the outcome of infection and discuss how manipulating this equilibrium might be exploited therapeutically.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15785761     DOI: 10.1038/ni1181

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  360 in total

1.  Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes.

Authors:  Keli L Hippen; Christoph Bucher; Dawn K Schirm; Amanda M Bearl; Ty Brender; Kathy A Mink; Kimberly S Waggie; Regis Peffault de Latour; Anne Janin; Julie M Curtsinger; Stacey R Dillon; Jeffrey S Miller; Gerard Socie; Bruce R Blazar
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  Placental malaria-associated suppression of parasite-specific immune response in neonates has no major impact on systemic CD4 T cell homeostasis.

Authors:  Valérie Soulard; Martin Amadoudji Zin; Catherine Fitting; Samad Ibitokou; Mayke Oesterholt; Adrian J F Luty; René-Xavier Perrin; Achille Massougbodji; Philippe Deloron; Antonio Bandeira; Nadine Fievet
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

3.  A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis.

Authors:  R Hernández-Pando; H Orozco-Esteves; H A Maldonado; D Aguilar-León; M M Vilchis-Landeros; D A Mata-Espinosa; V Mendoza; F López-Casillas
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

4.  FoxP3: A Key Player in T Regulatory Biology.

Authors:  D N Rao; Raza Ali Naqvi
Journal:  Indian J Clin Biochem       Date:  2011-02-04

Review 5.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

6.  Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection.

Authors:  Guoping Peng; Shuping Li; Wei Wu; Zhen Sun; Yiqiong Chen; Zhi Chen
Journal:  Immunology       Date:  2007-08-31       Impact factor: 7.397

7.  Diacylglycerol kinase ζ limits the generation of natural regulatory T cells.

Authors:  Amanda M Schmidt; Tao Zou; Rohan P Joshi; Theresa M Leichner; Matthew A Pimentel; Connie L Sommers; Taku Kambayashi
Journal:  Sci Signal       Date:  2013-11-26       Impact factor: 8.192

8.  Selective priming and expansion of antigen-specific Foxp3- CD4+ T cells during Listeria monocytogenes infection.

Authors:  James M Ertelt; Jared H Rowe; Tanner M Johanns; Joseph C Lai; James B McLachlan; Sing Sing Way
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  T regulatory cells distinguish two types of primary hypophysitis.

Authors:  S Mirocha; R B Elagin; S Salamat; J C Jaume
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

10.  [Viral infections].

Authors:  F Galán-Sánchez; C Fernández-Gutiérrez Del Álamo; M Rodríguez-Iglesias
Journal:  Medicine (Madr)       Date:  2014-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.